Opinion

Video

Empowering Patients: Defining Moderate Plaque Psoriasis and the Promise of Novel Oral Systemic Treatment

Plaque psoriasis experts explore recent advancements in treatment options, patient experiences, and the potential of novel oral systemic therapies to reduce the burden of this prevalent chronic condition.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Steven Fein, MD | Credit: University of Michigan
Related Content
CASPAR Criteria May Identify More Patients With Juvenile PsA Than ILAR Criteria
December 21st 2024

CASPAR Criteria May Identify More Patients With Juvenile PsA Than ILAR Criteria

Victoria Johnson
Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor
December 16th 2024

Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
FDA logo in black over a white background. | Credit: US Food and Drug Administration
December 20th 2024

FDA Issues CRL for Sotagliflozin in Type 1 Diabetes and CKD

Patrick Campbell
Irl Hirsch, MD | Credit: University of Washington
December 12th 2024

Diabetes Dialogue: Celebrating 25 Years of CGM, with Irl Hirsch, MD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Credit: Adobe Stock/ fizkes
December 20th 2024

Sedentary Behavior Linked to Increased Gout Risk Even Without Hyperuricemia

Chelsie Derman
Khurram Jamil, MD | Credit: Khurram Jamil on LinkedIn
December 20th 2024

Belapectin Misses Primary Endpoint in Phase 3 MASH Cirrhosis, Portal Hypertension Trial

Abigail Brooks, MA
© 2024 MJH Life Sciences

All rights reserved.